Sugentech (Korea) Performance
| 253840 Stock | KRW 5,060 255.00 5.31% |
The entity has a beta of -0.17, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sugentech are expected to decrease at a much lower rate. During the bear market, Sugentech is likely to outperform the market. At this point, Sugentech has a negative expected return of -0.33%. Please make sure to validate Sugentech's market risk adjusted performance, coefficient of variation, jensen alpha, as well as the relationship between the mean deviation and standard deviation , to decide if Sugentech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sugentech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -25.8 B |
Sugentech |
Sugentech Relative Risk vs. Return Landscape
If you would invest 628,000 in Sugentech on September 12, 2024 and sell it today you would lose (122,000) from holding Sugentech or give up 19.43% of portfolio value over 90 days. Sugentech is generating negative expected returns and assumes 3.0188% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Sugentech, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sugentech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sugentech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sugentech, and traders can use it to determine the average amount a Sugentech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1083
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 253840 |
Estimated Market Risk
| 3.02 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sugentech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sugentech by adding Sugentech to a well-diversified portfolio.
Sugentech Fundamentals Growth
Sugentech Stock prices reflect investors' perceptions of the future prospects and financial health of Sugentech, and Sugentech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sugentech Stock performance.
| Return On Equity | 50.19 | |||
| Return On Asset | 0.31 | |||
| Profit Margin | (0.64) % | |||
| Operating Margin | 0.58 % | |||
| Current Valuation | 293.17 B | |||
| Shares Outstanding | 11.43 M | |||
| Price To Sales | 3.39 X | |||
| Revenue | 77.2 B | |||
| EBITDA | 31.06 B | |||
| Cash And Equivalents | 66.1 B | |||
| Total Debt | 670.21 M | |||
| Debt To Equity | 0.05 % | |||
| Cash Flow From Operations | 38.96 B | |||
| Total Asset | 155.56 B | |||
About Sugentech Performance
By analyzing Sugentech's fundamental ratios, stakeholders can gain valuable insights into Sugentech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sugentech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sugentech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. Sugentech Inc. was founded in 2011 and is headquartered in Daejeon, South Korea. Sugentech is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Sugentech performance evaluation
Checking the ongoing alerts about Sugentech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sugentech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sugentech generated a negative expected return over the last 90 days | |
| Sugentech has high historical volatility and very poor performance | |
| About 19.0% of the company shares are owned by insiders or employees |
- Analyzing Sugentech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sugentech's stock is overvalued or undervalued compared to its peers.
- Examining Sugentech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sugentech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sugentech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sugentech's stock. These opinions can provide insight into Sugentech's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sugentech Stock analysis
When running Sugentech's price analysis, check to measure Sugentech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sugentech is operating at the current time. Most of Sugentech's value examination focuses on studying past and present price action to predict the probability of Sugentech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sugentech's price. Additionally, you may evaluate how the addition of Sugentech to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |